Alberto Scala

Alberto Scala

Auto-generated profile, based on publicly available information

Alberto Scala

Department of Medicine, University of Padova , Via Giustiniani 2, 35128 Padova

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2025 in European Eating Disorders Review
Verified
Journal Article
Open access
Paolo MeneguzzoPaolo Meneguzzo
Paolo Meneguzzo
MBMichela Biscaro
Michela Biscaro
LVLaura Vozzi
Laura Vozzi
MBMarina Bonato
Marina Bonato
ASAlberto Scala
Alberto Scala
AFAngela Favaro
Angela Favaro
Background: Gender‐diverse individuals are at elevated risk for disordered eating, shaped by body dissatisfaction, gender dysphoria, and minority stress. The roles of gender identity and expression, however, remain underexplored in clinical samples. This study examined how self‐perceived masculinity, femininity, and gender variance relate to eating behaviours in gender‐diverse adults seeking gender‐affirming care. Methods: Eighty‐four adults assigned female ( n = 50) or male ( n = 34) at birth were recruited from a regional gender incongruence clinic. Participants self‐identified as male ( n = 44), female ( n = 30), or non‐binary ( n = 10); 36 were receiving gender‐affirming hormone therapy (GAHT). They completed the Three‐Factor Eating Questionnaire (TFEQ) and the Gender Variance Scale (GVS), assessing masculinity, femininity, and deviation from cisnormative expectations. Regression models tested associations between gender traits and eating behaviours. Results: Masculinity was positively associated with cognitive restraint, while femininity correlated with emotional and uncontrolled eating. Gender variance was not significantly related to TFEQ; however, exploratory analyses suggested a modest quadratic trend with dysregulated eating. Eating behaviours did not differ by GAHT status. Conclusions: Gender expression, more than gender variance, appears to influence eating behaviours in gender‐diverse individuals. Clinicians should consider how masculinity‐ and femininity‐linked eating patterns shape assessment and intervention.

16 September 2025 in International Journal of Transgender Health
Verified
Journal Article
Closed access
MBMarina Bonato
Marina Bonato
ASAlberto Scala
Alberto Scala
RARiccardo Amaglio
Riccardo Amaglio
GFGiovanni Frattin
Giovanni Frattin
Paolo MeneguzzoPaolo Meneguzzo
Paolo Meneguzzo
MMMarina Miscioscia
Marina Miscioscia

28 December 2024 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
ASAlberto Scala
Alberto Scala
MBMarina Bonato
Marina Bonato
CBCamillo Barbisan
Camillo Barbisan
MMMarina Miscioscia
Marina Miscioscia
Andrea GarollaAndrea Garolla
Andrea Garolla

10 September 2026 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
CPChiara Parazzoli
Chiara Parazzoli
ADAndrea Delbarba
Andrea Delbarba
ASAlberto Scala
Alberto Scala
ABAlessandro Brunetti
Alessandro Brunetti
RCRoberto Castello
Roberto Castello
SBStefania Bonadonna
Stefania Bonadonna
Purpose: Transgender and gender diverse (TGD) individuals have various medical needs, but limited healthcare professionals’ expertise remains a major barrier to care. Data on the preparedness of Italian endocrinologists to provide TGD care are scarce. This study assessed Italian endocrinologists’ knowledge, clinical practice, and educational needs in gender-affirming care. Methods: A nationwide survey developed by the Association of Medical Endocrinologists (AME), with support from the Italian Society for Gender, Identity and Health, was distributed to all AME members in 2023. Multivariable logistic regression identified factors associated with knowledge, self-reported ability to manage gender-affirming hormone therapy (GAHT) and interest in further education. Results: Overall, 703 endocrinologists completed the survey. Only 8.4% reported frequent clinical involvement with TGD patients, and fewer than 15% considered themselves able to initiate and monitor GAHT. Previous education in gender-affirming care was the strongest determinant of knowledge (OR 14.3) and self-reported ability to manage GAHT (OR 4.4). Younger age was associated with greater knowledge but not with perceived clinical competence. Nevertheless, 90.4% expressed interest in further education. Conclusion: Italian endocrinologists show substantial gaps in preparedness for transgender care. Structured education in gender-affirming care is strongly associated with greater knowledge and self-reported ability to manage GAHT, supporting the implementation of educational programs to improve access to competent endocrine care for TGD individuals.

30 April 2026 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
ASAlberto Scala
Alberto Scala
ADAndrea Delbarba
Andrea Delbarba
CCChiara Ceolin
Chiara Ceolin
VCValentina Camozzi
Valentina Camozzi
SGSandro Giannini
Sandro Giannini
TVTommaso Vezzaro
Tommaso Vezzaro
Summary In transgender adults, reference-gender choice alters Z-scores and fracture-risk estimates. Z-scores differ by 0.4–0.6 SD, with male references identifying more individuals with low BMD for age, especially in those assigned male at birth. Dual-reference reporting is advisable until further evidence becomes available. Purpose Transgender individuals, especially those assigned male at birth (AMAB), exhibit lower bone mineral density (BMD) compared with the cisgender population. Interpretation of densitometric data is challenging, as the choice of reference gender can significantly influence Z-scores and fracture risk scores. This study aims to evaluate the impact of the gender reference database (male or female) on the assessment of BMD and fracture risk in transgender adults prior to gender-affirming hormone therapy (GAHT). Materials and methods We conducted a cross-sectional analysis of 249 transgender individuals (153 assigned female at birth – AFAB and 96 AMAB) aged 18–43 years, recruited in the Hospitals of Padua and Brescia (Italy). Z-scores were calculated using both male and female reference databases and FRAX scores were computed using both gender inputs. Associations with anthropometric, biochemical, and hormonal parameters were explored. Results Z-scores differed systematically depending on the reference gender, with mean ΔZ ranging 0.4–0.6 SD across skeletal sites. Switching reference databases frequently led to reclassification of BMD status. AMAB individuals showed a higher prevalence of low BMD for age, particularly when assessed against male references (27.1%), whereas AFAB participants generally maintained normal BMD. However, FRAX scores remained low. BMI and 25-OH vitamin D levels were independent predictors of BMD and Z-scores in AMAB individuals. Conclusions The choice of reference gender significantly influences densitometric interpretation in young transgender adults. Until further evidence becomes available, calculating Z-scores using both male and female reference databases is advisable. Early preventive interventions remain essential to preserve bone health.

11 October 2026 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
MVMarco Vecchiato
Marco Vecchiato
LZLieve Mees van Zijverden
Lieve Mees van Zijverden
JHJason van Heesewijk
Jason van Heesewijk
ASAlberto Scala
Alberto Scala
ABAlessandro Biffi
Alessandro Biffi
DGDorte Glintborg
Dorte Glintborg
Transgender and gender-diverse (TGD) individuals represent a growing population with specific cardiovascular health needs. Current cardiovascular prevention strategies are largely derived from cisgender populations and may not adequately account for the combined effects of gender-affirming hormone therapy (GAHT) and other determinants. This expert opinion summarizes current evidence regarding cardiovascular health in TGD individuals, focusing on the cardiovascular effects of GAHT, population-specific cardiovascular risk factors, practical approaches to cardiovascular risk assessment, and future research priorities. Available evidence indicates that GAHT is associated with changes in cardiometabolic risk factors, haemostasis, vascular function, and cardiac physiology. Feminizing GAHT is associated with an increased risk of venous thromboembolism, whereas masculinizing GAHT is associated with adverse lipid changes, erythrocytosis, and a potentially increased risk of major cardiovascular events. However, causal inference is limited by the predominance of observational studies, relatively young study populations, heterogeneous GAHT regimens, short follow-up, and the absence of randomized study evidence. Population-level cardiovascular disparities in TGD individuals should not be attributed to GAHT alone as smoking, obesity, physical inactivity, minority stress, socioeconomic disadvantage, and unequal access to healthcare may independently or interactively influence cardiovascular risk. Current cardiovascular risk prediction tools have not been validated or calibrated in TGD populations and do not account for GAHT exposure or TGD-specific psychosocial and structural determinants. Cardiovascular risk assessment in TGD individuals should integrate conventional risk factors, transgender-related cardiovascular risk factors, and patient involvement regarding individual goals. A coordinated multidisciplinary approach may facilitate personalized cardiovascular prevention while supporting access to gender-affirming care. Future research should prioritize long-term prospective studies and the development of risk prediction models tailored to TGD populations.